The Summerlin Hospital Medical Center is a private, for-profit hospital owned by Universal Health Services and operated by the Valley Health System. It is located in the Summerlin neighborhood of Las Vegas, Nevada. As of 2018, the Summerlin Hospital offers 485 beds with private rooms.

There are 485 beds in Summerlin Hospital Medical Center.

During the past decade, Summerlin Hospital Medical Center conducted 160 clinical trials. In the 10-year time frame, 160 clinical trials started and 72 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 65 clinical trials were completed. i.e. 122.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Summerlin Hospital Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 98 trials, followed by "Children's Oncology Group" with 50 trials sponsored, "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Summerlin Hospital Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Children's Oncology Group" with 4 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Summerlin Hospital Medical Center" are "Recurrent Neuroblastoma" (12 trials), "Recurrent Osteosarcoma" (12 trials), "Malignant Solid Neoplasm" (11 trials), "Recurrent Malignant Solid Neoplasm" (11 trials) and "Refractory Malignant Solid Neoplasm" (11 trials). Many other conditions were trialed in "Summerlin Hospital Medical Center" in a lesser frequency.

Most popular intervention types in "Summerlin Hospital Medical Center" are "Drug" (165 trials), "Other" (145 trials), "Biological" (82 trials), "Procedure" (70 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (82 trials), "Quality-of-Life Assessment" (46 trials), "Biospecimen Collection" (37 trials), "Questionnaire Administration" (35 trials) and "Computed Tomography" (34 trials). Other intervention names were less common.

The vast majority of trials in "Summerlin Hospital Medical Center" are 199 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Summerlin Hospital Medical Center". undefined are not yet recruiting, 69 are recruiting, 112 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Summerlin Hospital Medical Center, 5 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Summerlin Hospital Medical Center, 3 "Phase 1" clinical trials were conducted, 96 "Phase 2" clinical trials and 102 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".